republic-os/legislation/us/states/va/2021/sb-1469.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Opioid Abatement Authority; established, Fund created, report, membership.	Establishing an Opioid Abatement Authority.Establishes the Opioid Abatement Authority. The Authority, with theassistance of the Office of the Attorney General, would administerthe Opioid Abatement Fund, which would receive moneys from settlements,judgments, verdicts, and other court orders, or related agreements,concerning claims regarding the manufacturing, marketing, distribution,or sale of opioids that would be used to provide grants and loans to Virginia agencies and certain localities for the purpose of treating, preventing, and reducing opioid use disorder and the misuse of opioidsin the Commonwealth.	us/states/va	Virginia General Assembly	2021	SB 1469	Virginia SB 1469 (2021)	bill		enacted	George L. Barker	6	51	11	2021-01-22	2021-03-24	openstates	ocd-bill/bdd34db3-edfd-465f-8cb4-ad7b211db92e	https://lis.virginia.gov/cgi-bin/legp604.exe?212+sum+SB1469	a7f06fd849682d29688fa45b32aa6af84488a2c861d10798e665c8b64422b9e6	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia SB 1469 (2021) — Opioid Abatement Authority; established, Fund created, report, membership.

Establishing an Opioid Abatement Authority.Establishes the Opioid Abatement Authority. The Authority, with theassistance of the Office of the Attorney General, would administerthe Opioid Abatement Fund, which would receive moneys from settlements,judgments, verdicts, and other court orders, or related agreements,concerning claims regarding the manufacturing, marketing, distribution,or sale of opioids that would be used to provide grants and loans to Virginia agencies and certain localities for the purpose of treating, preventing, and reducing opioid use disorder and the misuse of opioidsin the Commonwealth.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. CHAP0307 (committee substitute) — source
2. Committee substitute printed 21104375D-S1 (committee substitute) — source
3. Committee substitute printed 21200113D-H1 (committee substitute) — source
4. Presented and ordered printed 21103486D (committee substitute) — source
5. SB1469ER (committee substitute) — source
6. SB1469ES1 (committee substitute) — source

Votes

• Continued to Special Session 1 in General Laws — 0–0 (fail) · lower
• Read third time and passed Senate (36-Y 0-N 2-A) — 36–0 (pass) · upper
• VOTE: Passage (91-Y 7-N) — 90–7 (pass) · lower
• Conference report agreed to by Senate (36-Y 0-N 3-A) — 36–0 (pass) · upper
• Reported from Finance and Appropriations with substitute (14-Y 0-N 2-A) — 14–0 (pass) · upper
• Senate acceded to request (39-Y 0-N) — 39–0 (pass) · upper
• Reported from General Laws with substitute (20-Y 2-N) — 20–2 (pass) · lower
• Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
• House substitute rejected by Senate (0-Y 38-N 1-A) — 0–38 (fail) · upper
• Reported from General Laws and Technology (13-Y 0-N) — 13–0 (pass) · upper
• VOTE: Agreed To (90-Y 7-N) — 89–7 (pass) · lower

Sponsors

• George L. Barker — primary (person)
• Joseph D. Morrissey — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2021-01-22 Presented and ordered printed 21103486D introduction
• 2021-01-22 Referred to Committee on General Laws and Technology referral-committee
• 2021-01-27 Reported from General Laws and Technology (13-Y 0-N) committee-passage
• 2021-01-27 Rereferred to Finance and Appropriations referral-committee
• 2021-02-01 Impact statement from DPB (SB1469)
• 2021-02-03 Senate committee, floor amendments and substitutes offered
• 2021-02-03 Reported from Finance and Appropriations with substitute (14-Y 0-N 2-A) committee-passage
• 2021-02-03 Committee substitute printed 21104375D-S1 substitution
• 2021-02-03 Constitutional reading dispensed (39-Y 0-N)
• 2021-02-04 Senate committee, floor amendments and substitutes offered
• 2021-02-04 Read second time reading-2
• 2021-02-04 Reading of substitute waived
• 2021-02-04 Committee substitute agreed to 21104375D-S1
• 2021-02-04 Reading of amendment waived
• 2021-02-04 Amendment by Senator Barker agreed to amendment-passage
• 2021-02-04 Engrossed by Senate - committee substitute with amendment SB1469ES1
• 2021-02-04 Printed as engrossed 21104375D-ES1
• 2021-02-05 Impact statement from DPB (SB1469ES1)
• 2021-02-05 Impact statement from DPB (SB1469S1)
• 2021-02-05 Read third time and passed Senate (36-Y 0-N 2-A) passage, reading-3
• 2021-02-07 Placed on Calendar
• 2021-02-07 Read first time reading-1
• 2021-02-07 Referred to Committee on General Laws referral-committee
• 2021-02-08 Continued to Special Session 1 in General Laws
• 2021-02-11 House committee, floor amendments and substitutes offered
• 2021-02-11 Reported from General Laws with substitute (20-Y 2-N) committee-passage
• 2021-02-11 Committee substitute printed 21200113D-H1 substitution
• 2021-02-15 Read second time reading-2
• 2021-02-15 Impact statement from DPB (SB1469H1)
• 2021-02-16 Read third time reading-3
• 2021-02-16 Committee substitute agreed to 21200113D-H1
• 2021-02-16 Engrossed by House - committee substitute SB1469H1
• 2021-02-16 Passed House with substitute (91-Y 7-N) passage
• 2021-02-16 VOTE: Passage (91-Y 7-N)
• 2021-02-18 House substitute rejected by Senate (0-Y 38-N 1-A)
• 2021-02-19 House insisted on substitute
• 2021-02-19 House requested conference committee
• 2021-02-23 Senate acceded to request (39-Y 0-N)
• 2021-02-23 Conferees appointed by Senate
• 2021-02-24 Conferees appointed by House
• 2021-02-27 Amended by conference committee
• 2021-02-27 Conference report agreed to by Senate (36-Y 0-N 3-A)
• 2021-02-27 Conference report agreed to by House (90-Y 7-N)
• 2021-02-27 VOTE: Agreed To (90-Y 7-N)
• 2021-03-09 Enrolled
• 2021-03-09 Signed by President
• 2021-03-10 Impact statement from DPB (SB1469ER)
• 2021-03-11 Signed by Speaker
• 2021-03-15 Enrolled Bill Communicated to Governor on March 15, 2021
• 2021-03-15 Governor's Action Deadline 11:59 p.m., March 31, 2021
• 2021-03-24 Approved by Governor-Chapter 307 (effective 7/1/21) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/bdd34db3-edfd-465f-8cb4-ad7b211db92e. Confidence: reported (aggregated from official Virginia legislature records).